We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£885.00
New to our records — first sighting 25 days ago. We'll learn its rhythm.
25 days of data · current price £885
The 2026-2031 World Outlook for Beta Interferon Therapeutics for Multiple Sclerosis
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 3 days · 3 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 3 days • 1 price levels
Price Analysis
Most common price: £885 (3 days, 100.0%)
Price range: £885 - £885
Price levels: 1 different prices over 3 days
Product Specifications
- Format
- paperback
- ASIN
- B0FGJKL1ZN
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 04 June 2025
- Listed Since
- 03 July 2025
Similar Products You Might Like
The 2026-2031 World Outlook for Oligonucleotide Therapeutics for Neurological Disorders
The 2026-2031 World Outlook for Nuclear Medicine Therapeutics
The 2026-2031 World Outlook for Spinal Muscular Atrophy
The 2026-2031 World Outlook for Lysosomal Storage Diseases Therapeutics
The 2026-2031 World Outlook for Infectious Disease Treatments
The 2026-2031 World Outlook for Oligonucleotide Therapeutics
The 2026-2031 World Outlook for Lysosomal Storage Diseases Treatments
The 2026-2031 World Outlook for Combination Antibody Therapies
The 2026-2031 World Outlook for Bone Morphogenetic Proteins
The 2026-2031 World Outlook for Hydroxychloroquine
The 2026-2031 World Outlook for Nuclear Medicine-Radiopharmaceuticals
The 2026-2031 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
The 2026-2031 World Outlook for Infectious Disease Drugs
The 2026-2031 World Outlook for Epilepsy Drugs
The 2026-2031 World Outlook for Nuclear Medicines
The 2026-2031 World Outlook for Allergy Immunotherapies
The 2026-2031 World Outlook for Biophotonics
The 2026-2031 World Outlook for Neurostimulation
The 2026-2031 World Outlook for Idiopathic Pulmonary Fibrosis Treatments
The 2026-2031 World Outlook for Interleukin Inhibitors
The 2026-2031 World Outlook for Clostridium Difficile Treatments
The 2026-2031 World Outlook for Pulmonary Fibrosis Treatments
The 2026-2031 World Outlook for Complementary and Alternative Medicines
